Genebio Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Genebio General Information

Description

Developer of accurate bioinformatics software tools designed to serve the life science industry. The company's tools in the fields of drug design, target prediction, proteomics, small molecule identification, and flow cytometry data, and it bridges the gap between information gathering and knowledge generation with mass spectrometry characterization of proteins and small molecules as well as proteome imaging, enabling clients and partners to get specialization essential to proteomics research.

Contact Information

Website
www.genebio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Rue Michel-Servet 1
  • Geneva 4
  • 1206 Geneva
  • Switzerland
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Rue Michel-Servet 1
  • Geneva 4
  • 1206 Geneva
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genebio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 14-Nov-2024 Completed Out of Business
2. Early Stage VC 01-Apr-2000 Completed Generating Revenue
1. University Spin-Out 01-Jan-1997 Completed Startup
To view Genebio’s complete valuation and funding history, request access »

Genebio Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Genebio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2005006236-A2 System and method for scoring peptide mass fingerprinting Inactive 15-Jul-2003
WO-2005006236-A3 System and method for scoring peptide mass fingerprinting Inactive 15-Jul-2003
US-20050042682-A1 Using protein-matching as tool in diagnosis of metabolic disorders Inactive 15-Jul-2003
US-20040143402-A1 Signal detection based scoring system; generating a stochastic model based on match characteristics associated with the peptides and their fragments; making disease diagnosis based on the scored match between the peptides Active 29-Jul-2002
DE-03766573-T1 System and method for evaluating peptide considerations Pending 29-Jul-2002 G01N33/6818
To view Genebio’s complete patent history, request access »

Ready to get started?

Request a free trial

Genebio FAQs

  • When was Genebio founded?

    Genebio was founded in 1997.

  • Where is Genebio headquartered?

    Genebio is headquartered in Geneva, Switzerland.

  • What industry is Genebio in?

    Genebio’s primary industry is Enterprise Systems (Healthcare).

  • Is Genebio a private or public company?

    Genebio is a Private company.

  • What is Genebio’s current revenue?

    The current revenue for Genebio is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process